Molecular formula: C23H29N3O. Chemical name: 2-[4-(3-benzo[b][1]benzazepin-11-ylpropyl)piperazin-1-yl]ethanol. Used as antidepressant and adrenergic uptake inhibitor
Doxepin is a psychotropic agent approved for depression, anxiety, and insomnia. Developed by Pfizer and approved by FDA in 1969 as antidepressant. Commonly produces 5:1 racemic mixture of (E):(Z) stereoisomers
Fluoxetine is a second-generation SSRI approved in 1987. Treats major depressive disorder, OCD, bulimia, and panic disorder. Used for premenstrual dysphoric disorder in female patients. Can be combined with olanzapine for bipolar I depression
Reserpine treats high blood pressure in combination with diuretics or vasodilators. Combined treatment reduces mortality in hypertension patients. Daily dose ranges from 0.05 to 0.25 mg for hypertension treatment. Used for psychotic symptoms, especially in schizophrenia
Opipramol is a tricyclic antidepressant used throughout Europe. Developed by Schindler and Blattner in 1961. Marketed under brand names Insidon and Pramolan
Prozac is an SSRI antidepressant preventing brain serotonin reabsorption. Helps maintain serotonin levels for mood regulation. May enhance therapy effectiveness when combined with psychotherapy